Thalidomide treatment of resistant or relapsed multiple myeloma patients.Marek Hus, Joanna Mańko, Teresa Wolska-Smoleń et al.|PubMed|2001Cited by 85
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myelomaMarek Hus, Anna Dmoszyńska, Maria Cioch et al.|Annals of Hematology|2011Cited by 62
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells numberMonika Podhorecka, Marek Hus, Agnieszka Szymczyk et al.|Oncotarget|2017Cited by 34